BCG vaccine: long-term protection against TB

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2004

Schlagwörter:	Tuberculosis Isoniazid American Medical Association Vaccine Efficacy Protective Efficacy

Anmerkung:	© Adis International Ltd 2004

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1437(2004), 1 vom: Mai, Seite 15-15
Übergeordnetes Werk:	volume:1437 ; year:2004 ; number:1 ; month:05 ; pages:15-15

Links:	Volltext

DOI / URN:	10.2165/00128413-200414370-00030

Katalog-ID:	SPR035186941

Internformat


LEADER	01000caa a22002652 4500
001	SPR035186941
003	DE-627
005	20230520004636.0
007	cr uuu---uuuuu
008	201007s2004 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200414370-00030 \|2 doi
035			\|a (DE-627)SPR035186941
035			\|a (SPR)00128413-200414370-00030-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a BCG vaccine: long-term protection against TB
264		1	\|c 2004
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2004
650		4	\|a Tuberculosis \|7 (dpeaa)DE-He213
650		4	\|a Isoniazid \|7 (dpeaa)DE-He213
650		4	\|a American Medical Association \|7 (dpeaa)DE-He213
650		4	\|a Vaccine Efficacy \|7 (dpeaa)DE-He213
650		4	\|a Protective Efficacy \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1437(2004), 1 vom: Mai, Seite 15-15 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1437 \|g year:2004 \|g number:1 \|g month:05 \|g pages:15-15
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200414370-00030 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_206
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_4305
951			\|a AR
952			\|d 1437 \|j 2004 \|e 1 \|c 05 \|h 15-15

Indexfelder

matchkey_str	article:22306056:2004----::cvcieogemrtci
hierarchy_sort_str	2004
publishDate	2004
allfields	10.2165/00128413-200414370-00030 doi (DE-627)SPR035186941 (SPR)00128413-200414370-00030-e DE-627 ger DE-627 rakwb eng BCG vaccine: long-term protection against TB 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Tuberculosis (dpeaa)DE-He213 Isoniazid (dpeaa)DE-He213 American Medical Association (dpeaa)DE-He213 Vaccine Efficacy (dpeaa)DE-He213 Protective Efficacy (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1437(2004), 1 vom: Mai, Seite 15-15 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1437 year:2004 number:1 month:05 pages:15-15 https://dx.doi.org/10.2165/00128413-200414370-00030 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1437 2004 1 05 15-15
spelling	10.2165/00128413-200414370-00030 doi (DE-627)SPR035186941 (SPR)00128413-200414370-00030-e DE-627 ger DE-627 rakwb eng BCG vaccine: long-term protection against TB 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Tuberculosis (dpeaa)DE-He213 Isoniazid (dpeaa)DE-He213 American Medical Association (dpeaa)DE-He213 Vaccine Efficacy (dpeaa)DE-He213 Protective Efficacy (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1437(2004), 1 vom: Mai, Seite 15-15 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1437 year:2004 number:1 month:05 pages:15-15 https://dx.doi.org/10.2165/00128413-200414370-00030 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1437 2004 1 05 15-15
allfields_unstemmed	10.2165/00128413-200414370-00030 doi (DE-627)SPR035186941 (SPR)00128413-200414370-00030-e DE-627 ger DE-627 rakwb eng BCG vaccine: long-term protection against TB 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Tuberculosis (dpeaa)DE-He213 Isoniazid (dpeaa)DE-He213 American Medical Association (dpeaa)DE-He213 Vaccine Efficacy (dpeaa)DE-He213 Protective Efficacy (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1437(2004), 1 vom: Mai, Seite 15-15 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1437 year:2004 number:1 month:05 pages:15-15 https://dx.doi.org/10.2165/00128413-200414370-00030 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1437 2004 1 05 15-15
allfieldsGer	10.2165/00128413-200414370-00030 doi (DE-627)SPR035186941 (SPR)00128413-200414370-00030-e DE-627 ger DE-627 rakwb eng BCG vaccine: long-term protection against TB 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Tuberculosis (dpeaa)DE-He213 Isoniazid (dpeaa)DE-He213 American Medical Association (dpeaa)DE-He213 Vaccine Efficacy (dpeaa)DE-He213 Protective Efficacy (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1437(2004), 1 vom: Mai, Seite 15-15 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1437 year:2004 number:1 month:05 pages:15-15 https://dx.doi.org/10.2165/00128413-200414370-00030 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1437 2004 1 05 15-15
allfieldsSound	10.2165/00128413-200414370-00030 doi (DE-627)SPR035186941 (SPR)00128413-200414370-00030-e DE-627 ger DE-627 rakwb eng BCG vaccine: long-term protection against TB 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Tuberculosis (dpeaa)DE-He213 Isoniazid (dpeaa)DE-He213 American Medical Association (dpeaa)DE-He213 Vaccine Efficacy (dpeaa)DE-He213 Protective Efficacy (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1437(2004), 1 vom: Mai, Seite 15-15 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1437 year:2004 number:1 month:05 pages:15-15 https://dx.doi.org/10.2165/00128413-200414370-00030 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1437 2004 1 05 15-15
language	English
source	Enthalten in Inpharma weekly 1437(2004), 1 vom: Mai, Seite 15-15 volume:1437 year:2004 number:1 month:05 pages:15-15
sourceStr	Enthalten in Inpharma weekly 1437(2004), 1 vom: Mai, Seite 15-15 volume:1437 year:2004 number:1 month:05 pages:15-15
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Tuberculosis Isoniazid American Medical Association Vaccine Efficacy Protective Efficacy
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2004-05-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035186941
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035186941</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230520004636.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2004 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200414370-00030</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035186941</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200414370-00030-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">BCG vaccine: long-term protection against TB</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2004</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2004</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tuberculosis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Isoniazid</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">American Medical Association</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccine Efficacy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protective Efficacy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1437(2004), 1 vom: Mai, Seite 15-15</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1437</subfield><subfield code="g">year:2004</subfield><subfield code="g">number:1</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:15-15</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200414370-00030</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1437</subfield><subfield code="j">2004</subfield><subfield code="e">1</subfield><subfield code="c">05</subfield><subfield code="h">15-15</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	BCG vaccine: long-term protection against TB Tuberculosis (dpeaa)DE-He213 Isoniazid (dpeaa)DE-He213 American Medical Association (dpeaa)DE-He213 Vaccine Efficacy (dpeaa)DE-He213 Protective Efficacy (dpeaa)DE-He213
topic	misc Tuberculosis misc Isoniazid misc American Medical Association misc Vaccine Efficacy misc Protective Efficacy
spellingShingle	misc Tuberculosis misc Isoniazid misc American Medical Association misc Vaccine Efficacy misc Protective Efficacy BCG vaccine: long-term protection against TB
topic_unstemmed	misc Tuberculosis misc Isoniazid misc American Medical Association misc Vaccine Efficacy misc Protective Efficacy
topic_browse	misc Tuberculosis misc Isoniazid misc American Medical Association misc Vaccine Efficacy misc Protective Efficacy
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	BCG vaccine: long-term protection against TB
ctrlnum	(DE-627)SPR035186941 (SPR)00128413-200414370-00030-e
title_full	BCG vaccine: long-term protection against TB
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2004
contenttype_str_mv	txt
container_start_page	15
container_volume	1437
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200414370-00030
title_sort	bcg vaccine: long-term protection against tb
title_auth	BCG vaccine: long-term protection against TB
abstract	© Adis International Ltd 2004
abstractGer	© Adis International Ltd 2004
abstract_unstemmed	© Adis International Ltd 2004
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305
container_issue	1
title_short	BCG vaccine: long-term protection against TB
url	https://dx.doi.org/10.2165/00128413-200414370-00030
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200414370-00030
up_date	2024-07-03T13:49:42.435Z
_version_	1803566010798702592
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035186941</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230520004636.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2004 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200414370-00030</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035186941</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200414370-00030-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">BCG vaccine: long-term protection against TB</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2004</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2004</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tuberculosis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Isoniazid</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">American Medical Association</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccine Efficacy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protective Efficacy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1437(2004), 1 vom: Mai, Seite 15-15</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1437</subfield><subfield code="g">year:2004</subfield><subfield code="g">number:1</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:15-15</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200414370-00030</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1437</subfield><subfield code="j">2004</subfield><subfield code="e">1</subfield><subfield code="c">05</subfield><subfield code="h">15-15</subfield></datafield></record></collection>
score	7.403097

Nicht das Richtige dabei?

Schreiben Sie uns!

BCG vaccine: long-term protection against TB

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?